Harrow Health, Inc. (HROW) vs Tandem Diabetes Care, Inc. (TNDM)

A side-by-side comparison of Harrow Health, Inc. and Tandem Diabetes Care, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HROW vs TNDM

growth of $100 · dividends reinvested · last 10y
HROW +761.4% (+24.0%/yr)TNDM -78.8% (-14.4%/yr)HROW compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $10020182020202220242026$861$21
HROW TNDM

HROW vs TNDM: by the numbers

  • •HROW is the larger company ($1.13B vs $1.11B market cap).
  • •Both run net losses; TNDM's is the smaller (-6.08% vs -13.51% net margin).
  • •HROW grew revenue faster over the past five years (34.52% vs 11.48% CAGR).

Metrics side by side

Valuation

MetricHROWTNDM
P/S ratio4.101.06
P/B ratio74.438.49
FCF yield0.47%N/A

Profitability

MetricHROWTNDM
Gross margin73.28%56.01%
Operating margin14.18%-4.13%
Net margin-13.51%-6.08%
ROE-244.91%-48.56%
ROIC1.81%-4.77%

Growth (annualized)

MetricHROWTNDM
Revenue CAGR (5Y)34.52%11.48%
Total return CAGR (5Y)27.66%-32.93%

Frequently asked

Which has grown faster, HROW or TNDM?
Over the past five years, HROW grew revenue faster — HROW at a 34.52% CAGR versus TNDM at 11.48%.
How have HROW and TNDM total returns compared?
Over the past 10 years, HROW delivered 23.49% and TNDM delivered -14.43% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.